Sarda Proteins

{
  "main_header": {
    "sid": 599610,
    "name": "Sarda Proteins",
    "stock_name": "Sarda Proteins",
    "full_name": "Sarda Proteins Ltd",
    "name_url": "stocks-analysis/sarda-proteins",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "70.41",
    "chg": -3.7,
    "chgp": "-4.99%",
    "dir": -1,
    "prev_price": "74.11",
    "mcapval": "13.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 519242,
    "symbol": "",
    "ind_name": "Edible Oil",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE995U01011",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "53 ",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sarda-proteins-599610-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sarda Proteins Falls 9.74%: Sharp Gap Down and Persistent Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sarda-proteins-falls-974-sharp-gap-down-and-persistent-selling-pressure-3779896",
        "imagepath": "",
        "date": "2026-01-04 10:44:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Dec:</strong> Sharp gap down and intraday low at Rs.74.11 (-9.74%)</p>\n                    <p><strong>30 Dec - 2 Jan:</strong> Stock price remained static at Rs.74.11 despite Sensex gains</p>\n                    <p><strong>2 Jan:</strong> Week closes at Rs.74.11, down 9.74% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.82.11</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.74.11</div><div class=\"stat-change negative\">-9.74%</div></div>\n                    <div clas..."
      },
      {
        "title": "Sarda Proteins Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sarda-proteins-ltd-is-rated-strong-sell-3773095",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SardaProteinsLt_mojoScore_3773095.png",
        "date": "2025-12-29 10:10:04",
        "description": "Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Sarda Proteins Hits Intraday Low Amid Price Pressure and Market Headwinds",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sarda-proteins-hits-intraday-low-amid-price-pressure-on-29-dec-2025-3772947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SardaProteins_priceRelatedfactors_3772947.png",
        "date": "2025-12-29 10:08:00",
        "description": "Sarda Proteins experienced a significant intraday decline, touching a low of Rs 74.11, reflecting a price pressure of 9.74% during today’s trading session. The stock’s performance contrasted sharply with broader market trends, highlighting immediate pressures within the edible oil sector."
      },
      {
        "title": "Sarda Proteins Opens with Sharp Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sarda-proteins-opens-with-sharp-gap-down-amid-market-concerns-3772945",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SardaProteins_gapdown_3772945.png",
        "date": "2025-12-29 10:06:33",
        "description": "Sarda Proteins witnessed a significant gap down at the opening of trading today, with the stock price declining by 9.74% to open at Rs 74.11. This sharp drop reflects heightened market concerns within the edible oil sector, as the stock underperformed both its sector peers and the broader Sensex index."
      },
      {
        "title": "Sarda Proteins Sees Revision in Market Assessment Amid Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sarda-proteins-downgraded-to-strong-sell-amid-weak-fundamentals-and-risky-valuation-3755257",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SardaProteins_mojoScore_3755257.png",
        "date": "2025-12-10 10:10:07",
        "description": "Sarda Proteins has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. This adjustment highlights the evolving challenges faced by the edible oil company, particularly in its financial performance and valuation metrics."
      },
      {
        "title": "Sarda Proteins Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sarda-proteins-faces-severe-selling-pressure-as-stock-hits-lower-circuit-3748992",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SardaProteins_only_sellers_3748992.png",
        "date": "2025-12-05 12:45:37",
        "description": "Sarda Proteins Ltd has encountered significant selling pressure today, with the stock registering a sharp decline of 4.58% and exhibiting a complete absence of buyers. This distress selling comes amid a series of consecutive losses, signalling heightened market caution towards the edible oil company."
      },
      {
        "title": "Sarda Proteins Sees Extraordinary Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sarda-proteins-hits-upper-circuit-amidst-unprecedented-buying-interest-3748780",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SardaProteins_only_buyers_3748780.png",
        "date": "2025-12-05 10:55:23",
        "description": "Sarda Proteins has captured market attention with an unusual trading pattern characterised by an upper circuit lock and exclusively buy orders in the queue. This rare phenomenon highlights intense demand for the stock, with no sellers willing to part with shares, signalling a potential multi-day circuit scenario that investors are closely monitoring."
      },
      {
        "title": "Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sarda-proteins-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3746865",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SardaProteins_only_sellers_3746865.png",
        "date": "2025-12-04 14:01:21",
        "description": "Sarda Proteins Ltd is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading floor. The edible oil company’s shares have recorded consecutive declines, reflecting distress selling signals that have intensified over recent months."
      },
      {
        "title": "How has been the historical performance of Sarda Proteins?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-sarda-proteins-3739344",
        "imagepath": "",
        "date": "2025-12-01 23:28:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Operating Performance Trends</strong></p>\n<p>Over the past seven years, Sarda Proteins’ net sales have demonstrated considerable volatility. The company recorded ₹24.19 crores in net sales for the fiscal year ending March 2025, a sharp increase from ₹1.30 crores in the previous year. This surge follows a period of fluctuating sales, with figures ranging between ₹5.40 crores and ₹11.36 crores from 2019 to 2022. The absence of other operating income throughout this period indicates that the company’s revenue is primarily derived from its core operations.</p>\n<p>Despite the revenue fluctuations, the company’s total expenditure excluding depreciation closely tracks its operating income, reflecting a tight cost structure. Purchase of finished goods consistently represents the largest ..."
      }
    ],
    "total": 39,
    "sid": "599610",
    "stock_news_url": "https://www.marketsmojo.com/news/sarda-proteins-599610"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Dec-2025",
      "details": "Intimation of Trading Window Closure",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 08-12-2025",
      "datetime": "08-Dec-2025",
      "details": "Outcome of Board Meeting held on 08-12-2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "08-Dec-2025",
      "details": "Intimation of appointment of additional directors of the Company",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sarda Proteins Falls 9.74%: Sharp Gap Down and Persistent Selling Pressure

2026-01-04 10:44:00

Key Events This Week

29 Dec: Sharp gap down and intraday low at Rs.74.11 (-9.74%)

30 Dec - 2 Jan: Stock price remained static at Rs.74.11 despite Sensex gains

2 Jan: Week closes at Rs.74.11, down 9.74% for the week

Week Open

Rs.82.11

Week Close

Rs.74.11

-9.74%

Read full news article

Sarda Proteins Ltd is Rated Strong Sell

2025-12-29 10:10:04

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Sarda Proteins Hits Intraday Low Amid Price Pressure and Market Headwinds

2025-12-29 10:08:00

Sarda Proteins experienced a significant intraday decline, touching a low of Rs 74.11, reflecting a price pressure of 9.74% during today’s trading session. The stock’s performance contrasted sharply with broader market trends, highlighting immediate pressures within the edible oil sector.

Read full news article

Sarda Proteins Opens with Sharp Gap Down Amid Market Concerns

2025-12-29 10:06:33

Sarda Proteins witnessed a significant gap down at the opening of trading today, with the stock price declining by 9.74% to open at Rs 74.11. This sharp drop reflects heightened market concerns within the edible oil sector, as the stock underperformed both its sector peers and the broader Sensex index.

Read full news article

Sarda Proteins Sees Revision in Market Assessment Amid Challenging Fundamentals

2025-12-10 10:10:07

Sarda Proteins has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. This adjustment highlights the evolving challenges faced by the edible oil company, particularly in its financial performance and valuation metrics.

Read full news article

Sarda Proteins Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-05 12:45:37

Sarda Proteins Ltd has encountered significant selling pressure today, with the stock registering a sharp decline of 4.58% and exhibiting a complete absence of buyers. This distress selling comes amid a series of consecutive losses, signalling heightened market caution towards the edible oil company.

Read full news article

Sarda Proteins Sees Extraordinary Buying Interest Amid Upper Circuit Scenario

2025-12-05 10:55:23

Sarda Proteins has captured market attention with an unusual trading pattern characterised by an upper circuit lock and exclusively buy orders in the queue. This rare phenomenon highlights intense demand for the stock, with no sellers willing to part with shares, signalling a potential multi-day circuit scenario that investors are closely monitoring.

Read full news article

Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Losses

2025-12-04 14:01:21

Sarda Proteins Ltd is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading floor. The edible oil company’s shares have recorded consecutive declines, reflecting distress selling signals that have intensified over recent months.

Read full news article

How has been the historical performance of Sarda Proteins?

2025-12-01 23:28:35

Revenue and Operating Performance Trends

Over the past seven years, Sarda Proteins’ net sales have demonstrated considerable volatility. The company recorded ₹24.19 crores in net sales for the fiscal year ending March 2025, a sharp increase from ₹1.30 crores in the previous year. This surge follows a period of fluctuating sales, with figures ranging between ₹5.40 crores and ₹11.36 crores from 2019 to 2022. The absence of other operating income throughout this period indicates that the company’s revenue is primarily derived from its core operations.

Despite the revenue fluctuations, the company’s total expenditure excluding depreciation closely tracks its operating income, reflecting a tight cost structure. Purchase of finished goods consistently represents the largest ...

Read full news article

View All News